Histopathologic findings in retinoblastoma;Achados histopatológicos em retinoblastoma

Arquivos Brasileiros de Oftalmologia

Volumn 68, Issue 3, 2005, Pages 327-331

  Pessoa De Souza Filho, João ^a   Martins, Maria Cristina ^a,b   Torres, Virgínia Laura ^a   Toledo Dias, Ana Beatriz ^a   Serva Lowen, Márcia ^a   Afonso Pires, Luciana ^a   Erwenne, Clélia Maria ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIFESP ^*  (Brazil)

Author keywords

Choroid neoplasms pathology; Neoplasms invasiveness; Optic nerve neoplasms pathology; Retinoblastoma physiopathology; Risk factors

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER RADIOTHERAPY; CANCER SURGERY; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; CHOROIDITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; ENUCLEATION; FEMALE; HISTOPATHOLOGY; HUMAN; INFANT; IRIS; LASER COAGULATION; MALE; NEOVASCULARIZATION (PATHOLOGY); OPTIC NERVE; RETINOBLASTOMA; REVIEW; TUMOR DIFFERENTIATION;

EID: 28244499299     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/s0004-27492005000300010     Document Type: Review

References (19)

1. Lira RP, Leôncio MP, Pinho P, Rocha G, Lira PC. Retinoblastoma extra-ocular: estudo de 37 casos. Arq Bras Oftalmol. 1995;58(6):480-3.
2. Kronbauer FL, Corrêa ZM, Tyllmann C, Escovar CE, Marcon IM. O uso da quimioterapia no tratamento do retinoblastoma: avaliação retrospectiva. Arq Bras Oftalmol. 2000;63(6):481-6.
3. Marback, ED. Angiogênese tumoral como fator tumoral para disseminação da doença em retinoblastoma [tese]. São Paulo: Universidade Federal de São Paulo; 2001.
4. rd ed. Oxford: Butterrworth-Heinemann; 1994. p. 222-6.
5. Nehemy MB, Nehemy AL, Silva FA, Miranda D. Retinoblastoma em um olho atrófico. Arq Bras Oftalmol. 1991;54(2):90-2.
6. th Philadelphia: WB Saunders; 1996. p. 1340-75.
7. Singh AD, Shields CL, Shields JA. Prognostic factors in retinoblastoma. J Pediatr Ophthalmol Strabismus. 2000;37(3):134-41.
8. Khelfaoui F, Validire P, Auperin A, Quintana E, Michon J, Pacquement H, et al. Histopathologic risk factors in retinoblastoma. A retrospective study of 172 patients treated in a single institution. Cancer. 1996;77(6):1206-13.
9. Shields CL, Santos MC, Diniz W, Gündüz K, Mercado G, Cater JR, et al. Thermotherapy for retinoblastoma. Arch Ophthalmol. 1999;117(7):885-93.
10. Lumbroso L, Doz F, Urbieta M, Levy C, Bours D, Asselain B, et al. Chemothermotherapy in the management of retinoblastoma. Ophthalmology. 2002; 109(6):1130-6.
11. Friedman DL, Himelstein B, Shields CL, Shields JA, Needle M, Miller D, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol. 2000;18(1):12-7.
12. Schouten-van Meeteren AY, Van der Valk P, Van der Linden HC, Moll AC, Imhof SM, Huismans DR, et al. Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay. Cancer. 2001;92(11):2933-40.
13. Uusitalo MS, Van Quill K, Scott IU, Matthay KK, Murria TG, O'Brien JM. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination. Arch Ophthalmol 2001; 119(1):41-8.
14. Rubin CM, Robison LL, Cameron JD, Woods WG, Nesbit ME, Krivit W, et al. Intraocular retinoblastoma group V: an analysis of prognostic factors. J Clin Oncol. 1985;3(5):680-5.
15. Magramm I, Abramson DH, Ellsworth RM. Optic nerve involvement in retinoblastoma. Ophthalmology. 1989;96(2):217-22.
16. Pérez Samatier C, Travezán Carvo R, Salem Abugattas LE. Retinoblastoma: Histopathology study of 230 cases. Acta Cancerol. 1989;20(1):5-10.
17. Pe'er J, Neufeld M, Baras M, Gnessin H, Itin A, Keshet E. Rubeosis iridis in retinoblastoma. Histologic findings and the possible role for vascular endothelial growth factor in its induction. Ophthalmology. 1997;104(8):1251-8.
18. Shields CL, Shields JA, Baez K, Cater JR, De Potter P. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer. 1994;73(3): 692-8.
19. Demirci H, Eagle RC Jr, Shields CL, Shields JA. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction. Arch Ophthalmol. 2003;121(8):1125-31.